Finally, a complementary role of ProGRP and neuron-specific enolase (NSE) serum level was reported as a useful support to diagnose, monitor the effects of chemotherapy, and predict survival of SCLC patients [54,55]. This evidence concerns the gene GRP and small cell lung carcinoma.